Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.
Ontology highlight
ABSTRACT: Multiple pharmacotherapies for treating anxiety disorders exist, including selective serotonin reuptake inhibitors (SSRIs), the recommended first-line pharmacotherapy for pediatric anxiety. We sought to describe initial antianxiety medication use in children and estimate how long antianxiety medications were continued. In a large commercial claims database, we identified children (3-17 years) initiating prescription antianxiety medication from 2004 to 2014 with a recent anxiety diagnosis (ICD-9-CM = 293.84, 300.0x, 300.2x, 300.3x, 309.21, 309.81, 313.23). We estimated the proportion of children initiating each medication class across the study period and used multivariable regression to evaluate factors associated with initiation with an SSRI. We evaluated treatment length for each initial
SUBMITTER: Bushnell GA
PROVIDER: S-EPMC6468981 | biostudies-literature | 2018 Jan-Feb
REPOSITORIES: biostudies-literature
ACCESS DATA